Langue

Certains contenus peuvent être disponibles uniquement en anglais.

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Evidence, Guidelines and Recommendations

The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario. Provided by the Centre for Addiction and Mental Health (CAMH) and the College of Physicians and Surgeons of Ontario (CPSO)

Détails

Catégorie
Evidence, Guidelines and Recommendations
Format
Document PDF
Taille du fichier
1.40 MB
Téléchargements
59
Ajouté
25 août 2025
Tags
Psychiatrie
Douleur
Santé mentale
Troubles liés à l'usage de substances
Soins primaires
Médecine interne
Médecine d’urgence

Ressources connexes

Canadian Guideline for Opioids for Chronic Non-Cancer Pain
The Canadian Guideline for Opioid for Chronic Non-Cancer Pain was developed in response to concerns that Canadians are the second highest users per capita of opioids in the world, while the rates of opioid prescribing and opioid-related hospital visits and deaths have been increasing rapidly.